The liver clinic was establish in Tainan Yujing health center where two doctors from our association gave service to improve treatement accssibility and consultation for patients with chornic viral hepatitis every two weeks since 2011.03.
2011.08.30 Kaohsiung Research Association for the control of liver disease was set up.
2012.08.03 The first session of liver disease prevention seminars
2013.04.26 Director of the association performed liver uitrasound for HCC screeiong at Nanhua local health center.
2013.07.28 The second session of liver disease prevention seminars for World Hepatitis Day
— Final report of the project in BMSF Delivering Hope program
— Three hepatitis clinic nearly medical community are awarded (NT $ 2.5 million)
2014.04.12-13 Director of the association delivered health education lecture and performed liver uitrasound for HCC screeiong at Matsu health center.
2014.06.20 The first station of the hepatitis clinic was established–Changhua Tanaka clinic
2014.07.26 The public health education seminars for World Hepatitis Day
2014.07.30 The health education of hepatitis in Tainan Yujing health center
2014.08.19 The second station of the hepatitis clinic was established — Kaohsiung Ziguan health center
2014.12.08 The health education of hepatitis in Tainan Yujing health center
2015.01.07 The third station of the hepatitis clinic was established—Tainan Guantian health center
2015.04.10-11 Director of the association delivered health education lecture performed liver uitrasound for HCC screeiong at Matsu local health center.
2015.07.14 Members of BMSF Delivering Hope projects exchanged their experiences in Beijing
2015.07.26 The public health education seminars for World Hepatitis Day
2015.08.05 The press conference of liver disease prevention
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close